openPR Logo
Press release

Oncology Information System Market 2017, Future Industry Research, Trends, Forecast 2022

07-31-2017 01:10 PM CET | Health & Medicine

Press release from: Research Beam Market

Oncology Information System Market 2017, Future Industry

Oncology information systems is a software that is used to manage extensive cancer patient data and oversee procedures associated with oncology care. The advantages of using oncology information systems such as cost-saving, future-proofing, and environment-friendly, has increased the pressure on healthcare organization to upgrade their procedure from paper-based to paperless systems. The global oncology information systems market was valued at $2,247 million in 2015, and is estimated to reach $3,755 million by 2022, registering a CAGR of 7.5% 2016 to 2022.

For More Info, Get Sample : https://goo.gl/tMhptX

The global oncology information systems market is segmented based on products and services, applications, end user, and geography. Based on products and services, it is classified into software and services. Software segment is further bifurcated into patient information systems and treatment planning systems. Services are further segmented into consulting/optimization services, implementation services, and post-sale and maintenance services. Based on applications, it is categorized into radiation, medical, and surgical oncology. Based on end users, it is bifurcated into hospitals and oncology clinics, and research centers. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market growth is attributed to the surge in prevalence of cancer and technological advancements in oncology information systems, and the increase in disposable income among these patients. The benefits of using oncology information systems over conventional methods of record maintenance and treatment procedures, and rise in the healthcare expenditure are expected to increase the demand for these systems, thus fueling the market growth. However, dearth of healthcare IT professionals and high costs associated with oncology information systems are expected to hamper the growth.

KEY MARKET BENEFITS

• This report offers a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
• The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
• The global market is comprehensively analyzed with respect to products and services, application, end user, and geography.
• In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
• The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

Enquire About Report : https://goo.gl/mjSvUs

KEY PLAYERS PROFILED

• Accuray Incorporated
• Bogardus Medical Systems, Inc.
• Cerner Corporation
• CureMD Corporation
• Elekta AB
• Flatiron Health, Inc.
• Koninklijke Philips N.V.
• McKesson Corporation
• RaySearch Laboratories AB
• Varian Medical Systems, Inc.

KEY MARKET SEGMENTS

By Products and Services

• Software
• Patient Information Systems
• Treatment Planning Systems
• Services
• Consulting/Optimization Services
• Implementation Services
• Post-sale & Maintenance Services

By Application

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Also Request For Discount : https://goo.gl/qwoJd3

By End User

• Hospitals and Oncology Clinics
• Research Centers

By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Republic of South Africa
• Saudi Arabia
• Rest of LAMEA
The other players of the catheters market include (companies not profiled in the report):

• IMPAC Medical Systems, Inc.
• Siemens Healthcare
• Epic Systems Corporation
• Bizmatics, Inc.
• Charm Health
• Cordata Healthcare Innovations, LLC.

Table Of Content

• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE
• CHAPTER 5 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
• CHAPTER 6 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
• CHAPTER 7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY GEOGRAPHY
• CHAPTER 8 COMPANY PROFILES

About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities.
Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Information System Market 2017, Future Industry Research, Trends, Forecast 2022 here

News-ID: 648560 • Views:

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% From 2017 To 2023.
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in

All 5 Releases


More Releases for Oncology

Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated